基本信息
浏览量:1
职业迁徙
个人简介
Dr. Humes’ research interest has spanned areas of stem cells, cell therapy, biomaterials, device fabrication, biomimetic membranes, nanofabrication and tissue engineering. He has published over 200 peer reviewed articles and book chapters and 85 issued or applied patents. He has had funding from NIH, NSF and DOD.
He is the scientific founder of several biotechnology spinout companies, including Nephros Therapeutics, RenaMed Biologics, CytoPherx and Innovative BioTherapies. These companies have translated the discoveries in his laboratory to treat acute and chronic renal failure, systemic inflammatory distress syndrome, and multiorgan failure. His group has been instrumental in developing cell-based and bioengineered devices for therapeutic applications in organ replacement therapy. These approaches have progressed into FDA approved IND and IDE Phase I/II. Phase II, and pivotal clinical trials.
研究兴趣
论文共 216 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Transplantation directno. 6 (2024): e1627-e1627
European journal of heart failureno. 3 (2024): 534-536
Scientific reportsno. 1 (2024): 13081-13081
Kidney Medicineno. 4 (2024): 100792-100792
Scientific reportsno. 1 (2024)
PloS oneno. 4 (2023): e0273138-e0273138
Angela J. Westover, Chris Pino,H. David Humes,Kelli A. Krallman,David J. Askenazi,Lenar T. Yessayan,Michaela Collins, Jessica Potts,Stuart L. Goldstein
PEDIATRIC NEPHROLOGY (2023): S5-S6
引用0浏览0引用
0
0
David Catanzaro,H David Humes,Stuart L Goldstein,Lenar T Yessayan,David A Catanzaro, Emily C Scribe, Sai Prasad Iyer,Kevin K Chung
crossref(2023)
Nephronno. 1 (2023): 43-53
加载更多
作者统计
#Papers: 216
#Citation: 7931
H-Index: 51
G-Index: 85
Sociability: 6
Diversity: 1
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn